The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genito-Urinary Drugs Market Research Report 2025
Synopsis
Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
The global Genito-Urinary Drugs market was valued at US$ 28510 million in 2023 and is anticipated to reach US$ 35930 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The Genito-Urinary Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the genitourinary system, which includes the reproductive organs and the urinary tract. This market encompasses various therapeutic areas such as erectile dysfunction, urinary incontinence, urinary tract infections, and prostate disorders. The Genito-Urinary Drugs market has been witnessing steady growth in recent years due to factors such as the increasing prevalence of genitourinary disorders, rising awareness about available treatment options, and advancements in drug development. Additionally, the aging population and changing lifestyle patterns have contributed to the market's expansion.
This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs.
Report Scope
The Genito-Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genito-Urinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genito-Urinary Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
AbbVie
GSK
Otsuka Pharmaceutical
Sanofi
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genito-Urinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
The global Genito-Urinary Drugs market was valued at US$ 28510 million in 2023 and is anticipated to reach US$ 35930 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The Genito-Urinary Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the genitourinary system, which includes the reproductive organs and the urinary tract. This market encompasses various therapeutic areas such as erectile dysfunction, urinary incontinence, urinary tract infections, and prostate disorders. The Genito-Urinary Drugs market has been witnessing steady growth in recent years due to factors such as the increasing prevalence of genitourinary disorders, rising awareness about available treatment options, and advancements in drug development. Additionally, the aging population and changing lifestyle patterns have contributed to the market's expansion.
This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs.
Report Scope
The Genito-Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genito-Urinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genito-Urinary Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
AbbVie
GSK
Otsuka Pharmaceutical
Sanofi
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genito-Urinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Genito-Urinary Drugs Market Overview
1.1 Product Overview and Scope of Genito-Urinary Drugs
1.2 Genito-Urinary Drugs Segment by Type
1.2.1 Global Genito-Urinary Drugs Market Value Comparison by Type (2024-2030)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Genito-Urinary Drugs Segment by Application
1.3.1 Global Genito-Urinary Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Genito-Urinary Drugs Market Size Estimates and Forecasts
1.4.1 Global Genito-Urinary Drugs Revenue 2019-2030
1.4.2 Global Genito-Urinary Drugs Sales 2019-2030
1.4.3 Global Genito-Urinary Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genito-Urinary Drugs Market Competition by Manufacturers
2.1 Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Genito-Urinary Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Genito-Urinary Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Genito-Urinary Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genito-Urinary Drugs, Product Type & Application
2.7 Genito-Urinary Drugs Market Competitive Situation and Trends
2.7.1 Genito-Urinary Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genito-Urinary Drugs Players Market Share by Revenue
2.7.3 Global Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genito-Urinary Drugs Retrospective Market Scenario by Region
3.1 Global Genito-Urinary Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genito-Urinary Drugs Global Genito-Urinary Drugs Sales by Region: 2019-2030
3.2.1 Global Genito-Urinary Drugs Sales by Region: 2019-2024
3.2.2 Global Genito-Urinary Drugs Sales by Region: 2025-2030
3.3 Global Genito-Urinary Drugs Global Genito-Urinary Drugs Revenue by Region: 2019-2030
3.3.1 Global Genito-Urinary Drugs Revenue by Region: 2019-2024
3.3.2 Global Genito-Urinary Drugs Revenue by Region: 2025-2030
3.4 North America Genito-Urinary Drugs Market Facts & Figures by Country
3.4.1 North America Genito-Urinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genito-Urinary Drugs Sales by Country (2019-2030)
3.4.3 North America Genito-Urinary Drugs Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Genito-Urinary Drugs Market Facts & Figures by Country
3.5.1 Europe Genito-Urinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genito-Urinary Drugs Sales by Country (2019-2030)
3.5.3 Europe Genito-Urinary Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genito-Urinary Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Genito-Urinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genito-Urinary Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Genito-Urinary Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Genito-Urinary Drugs Market Facts & Figures by Country
3.7.1 Latin America Genito-Urinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genito-Urinary Drugs Sales by Country (2019-2030)
3.7.3 Latin America Genito-Urinary Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genito-Urinary Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Genito-Urinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genito-Urinary Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genito-Urinary Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genito-Urinary Drugs Sales by Type (2019-2030)
4.1.1 Global Genito-Urinary Drugs Sales by Type (2019-2024)
4.1.2 Global Genito-Urinary Drugs Sales by Type (2025-2030)
4.1.3 Global Genito-Urinary Drugs Sales Market Share by Type (2019-2030)
4.2 Global Genito-Urinary Drugs Revenue by Type (2019-2030)
4.2.1 Global Genito-Urinary Drugs Revenue by Type (2019-2024)
4.2.2 Global Genito-Urinary Drugs Revenue by Type (2025-2030)
4.2.3 Global Genito-Urinary Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Genito-Urinary Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genito-Urinary Drugs Sales by Application (2019-2030)
5.1.1 Global Genito-Urinary Drugs Sales by Application (2019-2024)
5.1.2 Global Genito-Urinary Drugs Sales by Application (2025-2030)
5.1.3 Global Genito-Urinary Drugs Sales Market Share by Application (2019-2030)
5.2 Global Genito-Urinary Drugs Revenue by Application (2019-2030)
5.2.1 Global Genito-Urinary Drugs Revenue by Application (2019-2024)
5.2.2 Global Genito-Urinary Drugs Revenue by Application (2025-2030)
5.2.3 Global Genito-Urinary Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Genito-Urinary Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo Company
6.1.1 Daiichi Sankyo Company Corporation Information
6.1.2 Daiichi Sankyo Company Description and Business Overview
6.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio
6.1.5 Daiichi Sankyo Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Genito-Urinary Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Genito-Urinary Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Astellas Pharma
6.4.1 Astellas Pharma Corporation Information
6.4.2 Astellas Pharma Description and Business Overview
6.4.3 Astellas Pharma Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Pharma Genito-Urinary Drugs Product Portfolio
6.4.5 Astellas Pharma Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Genito-Urinary Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Genito-Urinary Drugs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.6.1 Otsuka Pharmaceutical Corporation Information
6.6.2 Otsuka Pharmaceutical Description and Business Overview
6.6.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Genito-Urinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Genito-Urinary Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genito-Urinary Drugs Industry Chain Analysis
7.2 Genito-Urinary Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genito-Urinary Drugs Production Mode & Process
7.4 Genito-Urinary Drugs Sales and Marketing
7.4.1 Genito-Urinary Drugs Sales Channels
7.4.2 Genito-Urinary Drugs Distributors
7.5 Genito-Urinary Drugs Customers
8 Genito-Urinary Drugs Market Dynamics
8.1 Genito-Urinary Drugs Industry Trends
8.2 Genito-Urinary Drugs Market Drivers
8.3 Genito-Urinary Drugs Market Challenges
8.4 Genito-Urinary Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
